These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 2744906

  • 1. Effect of diclofenac-Na on 24-hour urinary excretion of creatinine, calcium, uric acid and glycosaminoglycans in adult patients with recurrent calcium oxalate nephrolithiasis.
    Hemal AK, Sidhu H, Thind SK, Nath R, Vaidyanathan S.
    Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):44-6. PubMed ID: 2744906
    [Abstract] [Full Text] [Related]

  • 2. Idiopathic calcium nephrolithiasis. 2. Differences between hypercalciuric and normocalciuric persons with recurrent kidney stone formation and persons without such a history.
    Wilson DR, Pylypchuk G, Ehrig U.
    Can Med Assoc J; 1979 Mar 17; 120(6):666-9. PubMed ID: 436048
    [Abstract] [Full Text] [Related]

  • 3. [Sodium excretion in children with lithogenic disorders].
    Kovacević L, Kovacević S, Smoljanić Z, Peco-Antić A, Kostić N, Gajić M, Kovacević N, Jovanović O.
    Srp Arh Celok Lek; 1998 Mar 17; 126(9-10):321-6. PubMed ID: 9863402
    [Abstract] [Full Text] [Related]

  • 4. Significance of the calcium to creatinine concentration ratio of a single-voided urine specimen in patients with hypercalciuric urolithiasis.
    Matsushita K, Tanikawa K.
    Tokai J Exp Clin Med; 1987 Sep 17; 12(3):167-71. PubMed ID: 3454077
    [Abstract] [Full Text] [Related]

  • 5. The effect of diclofenac sodium on urinary concentration of calcium, uric acid and glycosaminoglycans in traumatic paraplegics.
    Sharma S, Vaidyanathan S, Thind SK, Nath R, Sankaranarayanan A.
    Br J Urol; 1991 Sep 17; 68(3):240-2. PubMed ID: 1913063
    [Abstract] [Full Text] [Related]

  • 6. [Urinary calculus protective side effects of anti-rheumatic therapy].
    Schlichter A, Brundig P.
    Z Urol Nephrol; 1990 Apr 17; 83(4):175-81. PubMed ID: 2378178
    [Abstract] [Full Text] [Related]

  • 7. Comparative study of the circadian rhythmicity in the urinary concentration of glycosaminoglycans in patients of calcium oxalate nephrolithiasis and in healthy adults.
    Sidhu H, Thind SK, Nath R, Vaidyanathan S, Hemal AK, Mandal AK, Krishan K.
    Urol Int; 1989 Apr 17; 44(4):218-21. PubMed ID: 2800054
    [Abstract] [Full Text] [Related]

  • 8. Body size and 24-hour urine composition.
    Taylor EN, Curhan GC.
    Am J Kidney Dis; 2006 Dec 17; 48(6):905-15. PubMed ID: 17162145
    [Abstract] [Full Text] [Related]

  • 9. [Effect of proteolytic enzymes, electrolytes and other factors on the crystallization of calcium oxalate in the urine].
    Börner RH, Brundig P, Mäurer F, Berg W, Baumann W.
    Z Urol Nephrol; 1983 May 17; 76(5):327-31. PubMed ID: 6224367
    [Abstract] [Full Text] [Related]

  • 10. Dietary oxalate and calcium oxalate nephrolithiasis.
    Khan SR, Glenton PA, Byer KJ.
    J Urol; 2007 Nov 17; 178(5):2191-6. PubMed ID: 17870111
    [Abstract] [Full Text] [Related]

  • 11. [The significance of hypocitruria in calcium oxalate induced nephrolithiasis].
    Horváth C, Németh J, Büki B, Vargha P.
    Orv Hetil; 1990 Nov 11; 131(45):2475-8. PubMed ID: 2234941
    [Abstract] [Full Text] [Related]

  • 12. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A, Meola M, D'Alessandro C, Bernabini G, Pasquali E, Carpi A, Barsotti G.
    Biomed Pharmacother; 2007 Jan 11; 61(1):86-90. PubMed ID: 17184967
    [Abstract] [Full Text] [Related]

  • 13. [The effect of oral calcium loading on the serum concentrations and urinary excretion of uric acid in patients with recurrent calcium nephrolithiasis and hypercalciuria].
    Ivanov I, Tsachev K.
    Vutr Boles; 1990 Jan 11; 29(3):64-8. PubMed ID: 2284802
    [Abstract] [Full Text] [Related]

  • 14. [Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers].
    Iguchi M, Ikegami M, Kiwamoto H, Umekawa T, Ishikawa Y, Kohri K, Kurita T.
    Hinyokika Kiyo; 1993 May 11; 39(5):425-31. PubMed ID: 8322624
    [Abstract] [Full Text] [Related]

  • 15. Idiopathic calcium nephrolithiasis. 1. Differences in urine crystalloids, urine saturation with brushite and urine inhibitors of calcification between persons with and persons without recurrent kidney stone formation.
    Pylypchuk G, Ehrig U, Wilson DR.
    Can Med Assoc J; 1979 Mar 17; 120(6):658-65. PubMed ID: 436047
    [Abstract] [Full Text] [Related]

  • 16. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML, Chi T, Eisner BH, Shami G, Gentle DL.
    J Urol; 2009 Mar 17; 181(3):1140-4. PubMed ID: 19152919
    [Abstract] [Full Text] [Related]

  • 17. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate.
    Pak CY, Peterson R.
    Arch Intern Med; 1986 May 17; 146(5):863-7. PubMed ID: 3963975
    [Abstract] [Full Text] [Related]

  • 18. The effect of Phyllanthus niruri on urinary inhibitors of calcium oxalate crystallization and other factors associated with renal stone formation.
    Freitas AM, Schor N, Boim MA.
    BJU Int; 2002 Jun 17; 89(9):829-34. PubMed ID: 12010223
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.